Deals of the week: Temasek backs Snyk; Haulio hauls in corporate money

THESE South-east Asian tech deals made headlines in the past week:

1. Temasek joins as new investor in Snyk's latest Series E round

London-based cybersecurity firm Snyk has raised US$300 million in Series E funding, bringing its valuation up four times to US$4.7 billion, it said.

Temasek Holdings joined in the latest funding round led by venture capital firms Accel and Tiger Global. Franklin Templeton and Atlassian Ventures joined as new investors.

2. Logistics tech firm Haulio bags pre-Series A investment

Singapore-based logistics firm Haulio has raised an undisclosed amount in a pre-Series A investment round.

A NEWSLETTER FOR YOU

Friday, 8.30 am

SGSME

Get updates on Singapore's SME community, along with profiles, news and tips.

Sign Up

Sign Up

The round was led by the corporate venture arm of YCH Group, Supply Chain Angels (SCAngels). Other investors include B7 Capital, GHS Ventures, Guava Capital, iSeed SEA, Iterative and PSA unboXed.

3. Healthtech startup Mesh Bio raises US$1.8 million

Singapore-based digital health startup Mesh Bio raised US$1.8 million in seed funding led by Elev8.vc and SEEDS Capital, with participation from Malaysia-based Citrine Capital and private equity fund manager TAEL Partners.

The fresh funds will go into accelerating the rollout of Mesh Bio's predictive analytics and workflow automation platform, DARA, in South-east Asia.

4. Temasek-backed Openspace Ventures closes third fund at US$200 million

Openspace Ventures, backed by Temasek, has closed its third South-east Asia fund at US$200 million, boosting the Singapore-based firm's total committed capital under management to US$425 million.

Investors in the new fund include Germany's DEG, Norway's Norfund AS, US asset manager 57 Stars LLC and Japan's Mizuho Financial Group.

Openspace was among the earliest investors in Gojek, the ride-hailing upstart that went on to become Indonesia's most valuable unicorn, as well as Biofourmis, which uses artificial intelligence to provide personalised care.